Free Access
Med Sci (Paris)
Volume 22, Number 12, Décembre 2006
Page(s) 1013 - 1014
Section Nouvelles
Published online 15 December 2006
  1. Johnson RT. Prion diseases. Lancet Neurol 2005; 4 : 635–42. [Google Scholar]
  2. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95 : 13363–83. [Google Scholar]
  3. Silveira JR, Raymon GJ, Hughson AG, et al. The most infectious prion protein particles. Nature 2005; 437 : 257–61. [Google Scholar]
  4. Brandner S, Isenmann S, Raeber A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996; 379 : 339–43 [Google Scholar]
  5. Mallucci G, Dickinson A, Linehan J, et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302 : 871–4. [Google Scholar]
  6. Chesebro B, Trifilo M, Race R, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308 : 1435–9. [Google Scholar]
  7. Hegde RS, Mastrianni JA, Scott MR, et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 1998; 279 : 827–34. [Google Scholar]
  8. Ma J, Wollmann R, Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2002; 298 : 1781–5. [Google Scholar]
  9. Dimcheff DE, Portis JL, Caughey B. Prion proteins meet quality control. Trends Cell Biol 2003; 13 : 337–40. [Google Scholar]
  10. Grenier C, Bissonnette C, Volkov L, Roucou X. Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells. J Neurochem 2006; 97 : 1456–66. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.